XPRESSPA GROUP INC (XSPA)

US98420U7037 - Common Stock

0.655  -0.04 (-5.65%)

After market: 0.6501 0 (-0.75%)

Fundamental Rating

3

XSPA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Diversified Consumer Services industry. The financial health of XSPA is average, but there are quite some concerns on its profitability. While showing a medium growth rate, XSPA is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year XSPA has reported negative net income.
In the past year XSPA had a positive cash flow from operations.
In the past 5 years XSPA reported 4 times negative net income.
XSPA had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -3.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -3.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

XSPA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XSPA has been increased compared to 1 year ago.
XSPA has a better debt/assets ratio than last year.

2.2 Solvency

XSPA has an Altman-Z score of -2.74. This is a bad value and indicates that XSPA is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for XSPA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.74
ROIC/WACCN/A
WACC8.27%

2.3 Liquidity

XSPA has a Current Ratio of 5.93. This indicates that XSPA is financially healthy and has no problem in meeting its short term obligations.
XSPA has a Quick Ratio of 5.84. This indicates that XSPA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 5.84

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.67% over the past year.
The Revenue has grown by 417.44% in the past year. This is a very strong growth!
The Revenue has been growing by 43.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-100%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Revenue growth Q2Q49.55%

3.2 Future

Based on estimates for the next years, XSPA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.45% on average per year.
Based on estimates for the next years, XSPA will show a small growth in Revenue. The Revenue will grow by 0.23% on average per year.
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

XSPA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XSPA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.35

4.3 Compensation for Growth

XSPA's earnings are expected to decrease with -11.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%

0

5. Dividend

5.1 Amount

XSPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XPRESSPA GROUP INC

NASDAQ:XSPA (10/24/2022, 7:00:02 PM)

After market: 0.6501 0 (-0.75%)

0.655

-0.04 (-5.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -0.24%
PM (TTM) -3.55%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.93
Quick Ratio 5.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-814%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y